Empowered to Test Yourself for Sexually Transmitted Diseases

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Texas at Austin, Austin, TX
Sexually Transmitted Diseases+2 More
Empowered to Test Yourself - Behavioral
Eligibility
< 65
Female
What conditions do you have?
Select

Study Summary

This trial will test a new way to get more black women in the South to test for HIV at home, which could lead to earlier treatment and prevention. Empowered to Test Yourself is an online treatment for Sexually Transmitted Diseases that has previously been approved by the FDA for a different condition. Unlike other trials, no patients in this trial will receive a placebo.

Eligible Conditions

  • Sexually Transmitted Diseases
  • Hiv
  • Economic Problems

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Sexually Transmitted Diseases

Study Objectives

5 Primary · 6 Secondary · Reporting Duration: Within 2 days of mailing the HIV home test.

Baseline assessment prior to intervention beginning
Demographic eligibility
Other demographics
Recruitment strategy
Sexual risk eligibility
During 28-day intervention
Retention
Week 1
Acceptability
Clear instructions
Feasibility
Measures appropriate and no errors
Day 2
Mailed HIV test
Mailed STI test
Day 4
Used Home HIV test
Day 4
Used home STI test
Day 7
Checked HIV results
Checked STI results
Day 7
Attended PrEP evaluation
Day 7
Received HIV treatment
Received STI treatment

Trial Safety

Safety Progress

1 of 3

Other trials for Sexually Transmitted Diseases

Trial Design

1 Treatment Group

Educational Control
1 of 1
Experimental Treatment

90 Total Participants · 1 Treatment Group

Primary Treatment: Empowered to Test Yourself · No Placebo Group · N/A

Educational Control
Behavioral
Experimental Group · 1 Intervention: Empowered to Test Yourself · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 2 days of mailing the hiv home test.
Closest Location: University of Texas at Austin · Austin, TX
Photo of Austin 1Photo of Austin 2Photo of Austin 3
2007First Recorded Clinical Trial
1 TrialsResearching Sexually Transmitted Diseases
52 CompletedClinical Trials

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
283 Previous Clinical Trials
67,151 Total Patients Enrolled
1 Trials studying Sexually Transmitted Diseases
400 Patients Enrolled for Sexually Transmitted Diseases
Liesl A Nydegger, PhDPrincipal InvestigatorUniversity of Texas at Austin

Eligibility Criteria

Age < 65 · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.